Jump to: Page Content, Site Navigation, Site Search,
You are seeing this message because your web browser does not support basic web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
BMJ 2006;332:1233 (27 May), doi:10.1136/bmj.332.7552.1233-a
New York Jeanne Lenzer
A secret Nigerian government report concluded that the drug manufacturer Pfizer undertook an “illegal trial of an unregistered drug” when the company enrolled nearly 100 Nigerian children with meningitis in a trial testing its antibiotic trovafloxacin (Trovan) against ceftriaxone during a 1996 meningitis epidemic.
Families of the children, their attorneys, and the media have been seeking the results of the report for five years without success until the report was leaked last week to the Washington Post (7 May, sect A: 1) by a source who asked to remain anonymous because of “personal safety” concerns.
The Washington Post article said that “aspects of the affair remain mysterious, such as why the report remains confidential.” The head of the investigative panel behind the report, Abdulsalami Nasidi, a virologist and senior Nigerian health official, told the Washington Post he did not know why the report was never released.
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
StumbleUpon
Technorati What's this?